Tectin: Key Regulator of Cell-Cell Adhesion (G79867)

Target Name: TCTN2

NCBI ID: G79867

TCTN2

Tectin: Key Regulator of Cell-Cell Adhesion

TCTN2 (TECT2), a protein that belongs to the Tectin family, is a protein that is expressed in various tissues of the body, including the brain, heart, liver, and pancreas. It is a key regulator of cell-cell adhesion, which is the process by which cells stick together to form tissues and organs.

Tectin is a transmembrane protein that consists of two subunits: Tectin subunit 1 (TN1) and Tectin subunit 2 (TN2). Both subunits contain a unique N-terminal region that is involved in the formation of the transmembrane domain. The transmembrane domain is responsible for the protein's ability to interact with various signaling molecules, as well as its ability to interact with other proteins that are expressed in the same cell or tissue.

One of the key functions of Tectin is its role in cell-cell adhesion. This is the process by which cells stick together to form tissues and organs. Tectin plays a key role in this process by helping to regulate the formation of tight junctions, which are the weakest type of cell-cell adhesion.

Tectin subunit 1 (TN1) is the N-terminus of the protein, and it contains a unique region that is involved in the formation of the transmembrane domain. This region is composed of a series of amino acids that are involved in the formation of a transmembrane domain that is able to interact with various signaling molecules.

One of the key functions of the transmembrane domain is its ability to interact with the protein known as FAK. FAK is a signaling molecule that is involved in a variety of processes in the body, including cell adhesion, migration, and invasion. Tectin subunit 1 (TN1) is able to interact with FAK through its transmembrane domain, which allows the protein to influence the activity of FAK.

Another function of Tectin is its role in the regulation of cell-cell adhesion. This is the process by which cells stick together to form tissues and organs. Tectin plays a key role in this process by helping to regulate the formation of tight junctions, which are the weakest type of cell-cell adhesion.

Tectin subunit 2 (TN2) is the C-terminus of the protein, and it contains a unique region that is involved in the formation of the transmembrane domain. This region is composed of a series of amino acids that are involved in the formation of a transmembrane domain that is able to interact with various signaling molecules.

One of the key functions of the transmembrane domain is its ability to interact with the protein known as PDGFR. PDGFR is a signaling molecule that is involved in a variety of processes in the body, including cell adhesion, migration, and invasion. Tectin subunit 2 (TN2) is able to interact with PDGFR through its transmembrane domain, which allows the protein to influence the activity of PDGFR.

In conclusion, Tectin is a transmembrane protein that is involved in a variety of processes in the body. Its key functions include cell-cell adhesion, the regulation of tight junctions, and the regulation of cell-cell adhesion. Tectin subunit 2 (TN2) is the C-terminus of the protein, and it contains a unique region that is involved in the formation of the transmembrane domain. This region is able to interact with various signaling molecules, including FAK and PDGFR. As a result, Tectin is a potential drug target and a biomarker for a variety of diseases.

Protein Name: Tectonic Family Member 2

Functions: Component of the tectonic-like complex, a complex localized at the transition zone of primary cilia and acting as a barrier that prevents diffusion of transmembrane proteins between the cilia and plasma membranes. Required for hedgehog signaling transduction (By similarity)

The "TCTN2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TCTN2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets